[
  {
    "ts": null,
    "headline": "Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)",
    "summary": "Bio-Techne recently announced a licensing agreement with Monod Bio, granting it exclusive commercial rights to a subset of AI-designed NovoBody™ Duo molecules for use in research and next-generation diagnostics. This collaboration expands Bio-Techne's recombinant protein and diagnostics portfolio and strengthens its position at the forefront of AI-powered precision medicine innovation. We'll explore how gaining exclusive access to cutting-edge AI-designed protein technologies could influence...",
    "url": "https://finnhub.io/api/news?id=f61c6f4cc374002c52e3de4c6db557163b3c55caa31b8dc703c7f31d680e617f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763709115,
      "headline": "Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)",
      "id": 137572810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne recently announced a licensing agreement with Monod Bio, granting it exclusive commercial rights to a subset of AI-designed NovoBody™ Duo molecules for use in research and next-generation diagnostics. This collaboration expands Bio-Techne's recombinant protein and diagnostics portfolio and strengthens its position at the forefront of AI-powered precision medicine innovation. We'll explore how gaining exclusive access to cutting-edge AI-designed protein technologies could influence...",
      "url": "https://finnhub.io/api/news?id=f61c6f4cc374002c52e3de4c6db557163b3c55caa31b8dc703c7f31d680e617f"
    }
  }
]